End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39,020 COP | +0.36% | +8.69% | +34.55% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.61 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Most analysts recommend that the stock should be sold or reduced.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+34.55% | 5.29B | B- | ||
+3.05% | 95.15B | B | ||
+1.78% | 94.71B | B- | ||
-20.65% | 77.24B | B+ | ||
+18.68% | 74.93B | D+ | ||
+6.69% | 30.04B | B | ||
+18.06% | 27.87B | B | ||
+4.32% | 26.97B | A | ||
-1.21% | 16.99B | C+ | ||
-9.10% | 15.16B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GRUPOSURA Stock
- Ratings Grupo de Inversiones Suramericana S.A.